Latest research report on “Biologics and Biosimilars Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5561163
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original innovator products, and can be manufactured when the original product’s patent expires.
This report contains market size and forecasts of Biologics and Biosimilars in global, including the following market information:
Global Biologics and Biosimilars Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Biologics and Biosimilars Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Biologics and Biosimilars companies in 2021 (%)
The global Biologics and Biosimilars market was valued at 198790 million in 2021 and is projected to reach US$ 277500 million by 2028, at a CAGR of 4.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biologics and Biosimilars include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologics and Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologics and Biosimilars Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, by Type, 2021 (%)
– Monoclonal Antibodies
– Interferon
– Erythropoietin
– Insulin
– Vaccines
– Others
Global Biologics and Biosimilars Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, by Application, 2021 (%)
– Tumor
– Diabetes
– Cardiovascular
– Hemophilia
– Others
Global Biologics and Biosimilars Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologics and Biosimilars revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biologics and Biosimilars revenues share in global market, 2021 (%)
Key companies Biologics and Biosimilars sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Biologics and Biosimilars sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Roche
– Amgen
– AbbVie
– Sanofi-Aventis
– Johnson & Johnson
– Pfizer
– Novo Nordisk
– Eli Lilly
– Novartis
– Merck
– 3sbio
– Changchun High Tech
– CP Guojian
– Biotech
– Gelgen
– Innovent
– Dong Bao
– Ganlee
– United Laboratories
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5561163
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441